Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 383

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 383
---
----------------------------|:----|:----------------|------:|:----|:-------|:--|:----|:----------|:-----|:--|:----|:-----------|:--|:----|:-------------|------:|:----|:---------------|:---------------|
| 2019                                       |     | March 2025 - April 2027     |     |                 |    44 |     |        | — |     |           | —    |   |     |            | — |     |              |    44 |     | $              | 0.14 - $21.80  |
| 2022                                       |     | August 2025 - December 2029 |     |                 |   123 |     |        | — |     |           | (6   | ) |     |            | — |     |              |   117 |     | $              | 0.14 - $168.35 |
| 2023                                       |     | December 2025 - April 2029  |     |                 | 3,211 |     |        | — |     |           | (780 | ) |     |            | — |     |              | 2,431 |     | $              | 3.25 - $5.26   |
| Total number of shares underlying warrants |     |                             |     |                 | 3,504 |     |        | — |     |           | (786 | ) |     |            | — |     |              | 2,718 |     |                |                |

Warrant Exercises During the year ended December 31, 2024, the Company issued 786,000 shares of its common stock upon exercise of warrants and received proceeds of $2,000. The exercise price of all shares exercised during the year ended December 31, 2024 ranged from $0.001 to $0.14. During the year ended December 31, 2023, the Company issued 696,000 shares of its common stock upon exercise of warrants and received proceeds of $30,000. The exercise price of all shares exercised during the year ended December 31, 2023 ranged from $0.001 to $0.14. Common Stock Upon completion of the Kineta-Yumanity Merger in December 2022, the number of authorized shares of common stock of the Company was adjusted to 125,000,000 with a par